2-es típusú cukorbetegség: vizsgálatok itt: Törökország

In Törökország 18 Also abroad 1200

18 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

No phaseTaking people
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Patients With Type 2 Diabetes
Where
Küçükçekmece
Életkor
18 év to 65 év
People
60
Run by
Hatice Zehra FERHATLAR
See details and how to joinNCT07927530
No phaseNot yet taking people in Törökország
Preoperative Gastric Ultrasound to Assess Stomach Contents and Aspiration Risk in Patients With Diabetes
Where
Diyarbakır
Életkor
18 év to 80 év
People
130
Run by
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
See details and how to joinNCT07929207
No phaseTaking people
Effect of Sensory Training on Functional Performance, Balance, Gait in Type 2 Diabetic Individuals With Neuropathy
Where
Van
Életkor
35 év to 65 év
People
40
Run by
Aylin DEMİR
See details and how to joinNCT06979401
3. fázisTaking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Adana, Ankara, Antalya, Istanbul, Izmir, Sariçam
Életkor
18 év and over
People
1600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
3. fázisTaking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Ankara, Antalya, Center, Istanbul
Életkor
18 év and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
No phaseTaking people
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
Where
Denizli
Életkor
18 év to 65 év
People
30
Run by
Pamukkale University
See details and how to joinNCT07924436
No phaseTaking people
Ocular Changes in Patients Using Tirzepatide or Semaglutide
Where
Istanbul
Életkor
18 év and over
People
40
Run by
Istanbul University
See details and how to joinNCT07924618
No phaseNot yet taking people in Törökország
Comparison of Functional Inspiratory Muscle Training and Combined Exercise Training in Individuals With Type 2 Diabetes
Where
Istanbul
Életkor
40 év to 65 év
People
39
Run by
İrem Çaylak Yetüt
See details and how to joinNCT07921901
3. fázisNot yet taking people in Törökország
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Adana, Ankara, Antalya, Diyarbakır, Eskişehir, Istanbul, Kayseri, Kocaeli, Yüreğir
Életkor
45 év to 64 év
People
3000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
3. fázisTaking people
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Where
Ankara, Gaziantep, Istanbul, Konya
Életkor
18 év and over
People
2000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00
3. fázisTaking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Adana, Afyonkarahisar, Ankara, Antalya, Bursa, Edirne, Istanbul, Izmir, Kayseri, Malatya, Zonguldak
Életkor
18 év and over
People
11 800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
No phaseTaking people
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
Where
Adana, Bakirkoy Istanbul, Basaksehir / Istanbul, Istanbul, Ümraniye / İstanbul
Életkor
18 év and over
People
270 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06704672
3. fázisTaking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Adana, Adapazarı, Ankara, Antalya, Istanbul
Életkor
18 év and over
People
4500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
3. fázisTaking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Adana, Ankara, Antalya, Bakırköy, Gaziantep, Kayseri, Yüreğir
Életkor
18 év and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
3. fázisTaking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Adana, Adana /yüreği̇r, Adapazarı/Turkiye, Afyonkarahisar, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Kocaeli, Nilüfer/Bursa, Odunpazarı /Eskişehir, Sivas, Sur / Diyarbakır
Életkor
45 év and over
People
1778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
3. fázisTaking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Where
Adana, Ankara, Bursa, Izmir, Kayseri, Samsun
Életkor
18 év and over
People
800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00
No phaseTaking people
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Where
Adana, Ankara, Gaziantep, Istanbul, Kayseri
Életkor
18 év and over
People
2150 worldwide
Run by
AstraZeneca
See details and how to joinNCT07606066
2. fázisTaking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Adana, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Kocaeli
Életkor
18 év and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00